Mandamus discussed in IN RE MEDICAL COMPONENTS, INC.,
posted by Lawrence B. Ebert at 3:28 PM
Friday, August 02, 2013
About Me
- Name: Lawrence B. Ebert
I'm a patent lawyer located in central New Jersey. I have a J.D. from the University of Chicago and a Ph.D. from Stanford University, where I studied graphite intercalation compounds at the Center for Materials Research. I worked at Exxon Corporate Research in areas ranging from engine deposits through coal and petroleum to fullerenes. An article that I wrote in The Trademark Reporter, 1994, 84, 379-407 on color trademarks was cited by Supreme Court in Qualitex v. Jacobson, 514 US 159 (1995) and the methodology was adopted in the Capri case in N.D. Ill. An article that I wrote on DNA profiling was cited by the Colorado Supreme Court (Shreck case) and a Florida appellate court (Brim case). I was interviewed by NHK-TV about the Jan-Hendrik Schon affair. I am developing ipABC, an entity that combines rigorous IP analytics with study of business models, to optimize utilization of intellectual property. I can be reached at C8AsF5 at yahoo.com.
Previous Posts
- Parties jointly move to waive FRCP 27(f); case goe...
- CAFC reverses ND CA in Plantronics v Aliph case
- Henry Ford and ethanol
- In re Harry: the facts exist where are they?
- Attorney argument nixed in Ex parte Qi
- Nonfunctional descriptive material discussed in Ex...
- Discussion of analogous art
- Patentee wins in Kilopass re-examination
- Examiner reversed in Ex parte Bayliss; LexisNexis ...
- 60 Minutes on July 28, 2013
0 Comments:
Post a Comment
<< Home